Accuray receives FDA 510(k) clearance for ClearRT imaging
Accuray received FDA 510(k) clearance for ClearRT Helical kVCT imaging on the Radixact system.
Evidence notes
- ClearRT is a helical fan-beam kVCT imaging system for Radixact.
- Accuray said commercial release was planned for spring 2021.
- The clearance added integrated imaging capability to the Radixact workflow.
Company context
Accuray develops and manufactures robotic radiosurgery and image-guided radiation therapy systems, including the CyberKnife and helical TomoTherapy and Radixact platforms.